-+ 0.00%
-+ 0.00%
-+ 0.00%

Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement In Response To Recent Accumulations Of Its Common Stock

Benzinga·03/13/2025 11:23:21
Listen to the news

The Rights Agreement will expire on March 11, 2026, or earlier, as provided in the Rights Agreement.

Under the Rights Agreement, the rights generally become exercisable if a person or a group of persons acquires beneficial ownership of 10% (or 20% in the case of certain investors filing on Schedule 13G) or more of the outstanding shares of Pliant common stock in a transaction not approved by the Board.